Projects funded by the NCN

New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Michał Karol Załuski

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Identification of Mycobacterium tuberculosis ligands binding human serum amyloid A (SAA) and biological function of tube...

Call: OPUS 12 , Panel: NZ7

Principal investigator: dr hab. Bożena Renata Dziadek

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Hyphenated separation techniques in the study of the molecular mechanisms of metabolic biotransformation of drugs for ta...

Call: SONATA 12 , Panel: ST4

Principal investigator: dr Małgorzata Szultka-Młyńska

Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Chemii

Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Anna Piotrowska-Murzyn

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha...

Call: SONATA 12 , Panel: NZ7

Principal investigator: dr hab. Anna Karolina Więckowska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Modeling of structure of gamma-aminobutyric acid transporters as an essential biological and therapeutic target

Call: SONATA 12 , Panel: NZ7

Principal investigator: dr hab. Marek Wojciech Bajda

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Nanomolecular antioxidants: biological basis of targeted therapy of neurodegenerative diseases.

Call: SONATA BIS 6 , Panel: NZ7

Principal investigator: dr hab. Izabela Anna Sadowska-Bartosz

Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

Structural studies of signaling receptors HVEM/CD160 as potential targets for immunoterapy against melanoma

Call: SONATA 11 , Panel: NZ1

Principal investigator: dr Marta Orlikowska

Uniwersytet Gdański, Wydział Chemii

Long non-coding RNAs (lncRNA) as treatment efficacy markers in patients with advanced melanoma harboring BRAF mutation.

Call: OPUS 11 , Panel: NZ7

Principal investigator: dr hab. Jacek Mackiewicz

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Nauk o Zdrowiu

New 2(5H)-furanone derivatives with tailored hydrophobicity of substitutents - synthesis, molecular targets, mechanism o...

Call: OPUS 11 , Panel: NZ7

Principal investigator: prof. Krzysztof Zdzisław Walczak

Politechnika Śląska, Wydział Chemiczny

Liposomal theranostic agent for magnetic resonance imaging and photodynamic therapy

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Paulina Krystyna Skupin-Mrugalska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Supramolecular compounds and their complexes with carbon nanotubes as potential systems for targeted delivery of drugs

Call: SONATA 11 , Panel: NZ1

Principal investigator: dr Anna Jagusiak

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Multifunctional inhibitors of beta-secretase with anti-aggregating properties of neurotoxic peptides - beta-amyloid and ...

Call: OPUS 11 , Panel: NZ7

Principal investigator: prof. Barbara Antonina Malawska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the exa...

Call: OPUS 11 , Panel: NZ4

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

INNOvative antiSEPTic agents for a therapy with a broad spectrum of action

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr Sebastian Kraszewski

Politechnika Wrocławska

In vitro and in vivo preclinical studies of NaA nanozeolite functionalized with antibodies anti-PSMA and labeled with ra...

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Anna Małgorzata Lankoff

Instytut Chemii i Techniki Jądrowej

Polymer-based nanostructures modified with biologically active substances for selective accumulation and release of drug...

Call: PRELUDIUM 10 , Panel: ST5

Principal investigator: Wioletta Sylwia Liwińska

Uniwersytet Warszawski, Wydział Chemii

Investigation of meluclar mechanism of new cell-based, targeted delivery method of anticancer drugs to the tumour tissue

Call: SONATA BIS 5 , Panel: NZ6

Principal investigator: dr hab. Magdalena Król

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Medycyny Weterynaryjnej

Developing of a new system for targeted anticancer therapy based on betulin derivetive and self-organizing polymeric nan...

Call: HARMONIA 7 , Panel: ST5

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

A coarse-grained model of protein - nanoparticles interactions for simulating the transport of drug molecules to their t...

Call: PRELUDIUM 9 , Panel: ST4

Principal investigator: dr Magdalena Anna Mozolewska

Uniwersytet Gdański, Wydział Chemii